CPT2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.437600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.604000E-01
Normal-vs-Stage2
8.798000E-01
Normal-vs-Stage3
3.637900E-02
Normal-vs-Stage4
5.291600E-01
Stage1-vs-Stage2
4.587400E-01
Stage1-vs-Stage3
1.076000E-01
Stage1-vs-Stage4
8.881800E-01
Stage2-vs-Stage3
8.971600E-02
Stage2-vs-Stage4
1.619550E-01
Stage3-vs-Stage4
1.392610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.176200E-01
Normal-vs-AfricanAmerican
7.687000E-01
Normal-vs-Asian
9.447200E-01
Caucasian-vs-AfricanAmerican
5.328600E-01
Caucasian-vs-Asian
7.297200E-01
AfricanAmerican-vs-Asian
7.923600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.002400E-01
Normal-vs-Female
7.769600E-01
Male-vs-Female
5.101200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.770000E-01
Normal-vs-Age(41-60Yrs)
8.651400E-01
Normal-vs-Age(61-80Yrs)
7.773000E-01
Normal-vs-Age(81-100Yrs)
7.911000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.656800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.797000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.561200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.110020E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.907000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.769600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.950800E-01
Normal-vs-Daily Drinker
7.510200E-01
Normal-vs-Weekly Drinker
2.091600E-01
Normal-vs-Occasional Drinker
7.000400E-01
Normal-vs-Social Drinker
6.441600E-01
Non Drinker-vs-Daily Drinker
9.176800E-01
Non Drinker-vs-Weekly Drinker
2.136800E-01
Non Drinker-vs-Occasional Drinker
2.092400E-01
Non Drinker-vs-Social Drinker
1.683570E-01
Daily Drinker-vs-Weekly Drinker
1.378620E-01
Daily Drinker-vs-Occasional Drinker
1.799210E-01
Daily Drinker-vs-Social Drinker
1.814450E-01
Weekly Drinker-vs-Occasional Drinker
2.404400E-02
Weekly Drinker-vs-Social Drinker
2.554100E-02
Occasional Drinker-vs-Social Drinker
8.126200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.217000E-01
Normal-vs-Grade 2
3.159600E-01
Normal-vs-Grade 3
2.628400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.630600E-01
Grade 1-vs-Grade 3
6.831400E-01
Grade 1-vs-Grade 4
4.217000E-01
Grade 2-vs-Grade 3
6.068400E-01
Grade 2-vs-Grade 4
3.159600E-01
Grade 3-vs-Grade 4
2.628400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.806800E-01
Normal-vs-NonDiabetic
8.683000E-01
Diabetic-vs-NonDiabetic
6.106200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.803400E-01
Normal-vs-NoPancreatitis
8.774800E-01
Pancreatitis-vs-NoPancreatitis
7.985400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.915000E-01
Normal-vs-N1
8.485800E-01
N0-vs-N1
3.161400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.780600E-01
Normal-vs-TP53-NonMutant
7.335000E-01
TP53-Mutant-vs-TP53-NonMutant
2.216400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
